You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 52, 5 August 2005
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 51, 10 June 2005) are a true and accurate record of that meeting.
CMEC recommends to the TGA that, subject to the resolution of outstanding chemistry and quality control issues, acetylated starch and acetylated oxidised starch are suitable for use as excipients in listed medicines.
|Complementary Medicines Evaluation Committee meeting 52 (pdf)||83KB|